🇺🇸 FDA
Pipeline program

hGH-ViaDerm™ System (hGH or somatropin)

GH-VD-102

Phase 1 small_molecule completed

Quick answer

hGH-ViaDerm™ System (hGH or somatropin) for Growth Hormone Deficiency is a Phase 1 program (small_molecule) at Teva Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Teva Pharma GmbH
Indication
Growth Hormone Deficiency
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials